Prescription practices, experiences, and perspectives on the usage of hydroxychloroquine among rheumatologists and other specialists
Background/Objectives: The use of hydroxychloroquine (HCQ) for COVID-19 has raised concerns for adverse effects. We aimed to understand the practice, perceptions, and experience of adverse drug reactions (ADRs) with HCQ use for COVID-19 and other indications. Methods: A validated e-survey with 30 qu...
Main Authors: | R Naveen, Alka Verma, Hussain Ahmed Raza, K G Chengappa, G S K R Naidu, Supriya Sharma, Ashish Goel, Durga Prasanna Misra, Aman Sharma, Latika Gupta, Vikas Agarwal |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Indian Journal of Rheumatology |
Subjects: | |
Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2021;volume=16;issue=2;spage=169;epage=178;aulast=Naveen |
Similar Items
-
Chloroquine and hydroxychloroquine – safety profile of potential COVID-19 drugs from the
rheumatologist’s perspective
by: Dominik Majewski, et al.
Published: (2021-03-01) -
The use of Hydroxychloroquine in the Treatment of COVID-19
by: Kamer TECEN-YÜCEL, et al.
Published: (2020-09-01) -
Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance
by: R. Choudhary, et al.
Published: (2020-05-01) -
Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine
by: David M. Stevens, et al.
Published: (2021-12-01) -
Hydroxychloroquine retinopathy: A review of imaging
by: Hemang K Pandya, et al.
Published: (2015-01-01)